Fat-1 Gene Delivery for Omega-6 to Omega-3 Conversion

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current research struggles to isolate and interpret the specific effects of different types of fats, such as saturated, monounsaturated, n-6 polyunsaturated, and n-3 polyunsaturated fatty acids, due to confounding variables in high-fat diet studies, leading to inconsistent conclusions regarding their impact on health.

Innovation Solution

The introduction of the fat-1 gene, encoding an omega-3 desaturase, is delivered via viral vectors or engineered probiotic bacteria to convert omega-6 fatty acids to omega-3 fatty acids, reducing the omega-6:omega-3 ratio and increasing omega-3 levels without genome editing, thereby addressing the imbalance and associated health issues.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If omega-6 fatty acids are supplemented in the diet to increase polyunsaturated fatty acid content, then the tissue content of essential fatty acids is improved, but the omega-6:omega-3 ratio becomes imbalanced and pro-inflammatory conditions worsen

Engineering Contradiction:
Improvepolyunsaturated fatty acid contentVSAvoidinflammation
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The fat-1 gene acts as an intermediary enzyme (omega-3 desaturase) that converts omega-6 fatty acids into omega-3 fatty acids within the body. This mediator transforms the harmful excess omega-6 into beneficial omega-3, resolving the imbalance without requiring direct omega-3 supplementation. The enzyme serves as a biological converter that addresses both the need for PUFA and the need for proper omega-6:omega-3 ratio.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention changes the biochemical parameter of fatty acid composition by introducing the fat-1 gene that catalyzes the conversion of omega-6 to omega-3 fatty acids. This parameter change directly alters the omega-6:omega-3 ratio in tissues, transforming the chemical composition to achieve anti-inflammatory effects while maintaining adequate PUFA levels.

Inventive Principle:
Principle #35Parameter changes

2Quantity of substance

If dietary supplements containing omega-3 fatty acids are used to increase omega-3 content, then the omega-3 levels are improved, but other confounding components in the supplements make it difficult to isolate the authentic effect of omega-3 fatty acids

Engineering Contradiction:
Improveomega-3 fatty acid contentVSAvoideffect isolation
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The invention extracts and isolates the specific function of omega-3 desaturase activity by introducing only the fat-1 gene encoding this enzyme. This separates the omega-3 production function from all other components present in dietary supplements, allowing researchers to study the authentic effect of increased omega-3 fatty acids without confounding variables from other supplement ingredients.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The fat-1 gene from C. elegans is copied and introduced into mammalian systems to create a controlled model where omega-3 fatty acid production can be precisely controlled and measured. This copying of the desaturase function into a different biological system allows for isolated study of omega-3 effects without the complexity of natural dietary sources.

Inventive Principle:
Principle #26Copying

3Quantity of substance

If high-fat diets are used to study fatty acid effects, then sufficient fat intake is provided, but the presence of multiple fat types and other components creates confounding variables that lead to inconsistent conclusions

Engineering Contradiction:
Improvefat intakeVSAvoiddiet composition complexity
Core Design Contradiction:
Quantity of substanceVSDevice complexity

Solution Approach 1:

The invention segments the complex function of fatty acid metabolism by specifically targeting and enhancing only the omega-3 desaturase activity through fat-1 gene delivery. This segmentation allows researchers to study the effect of a single metabolic parameter (omega-3 production) independent of other dietary fat components, simplifying the complex interaction of multiple fat types in high-fat diets.

Inventive Principle:
Principle #1Segmentation

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach effectively reduces systemic metabolic inflammation, improves bone microstructure, and mitigates conditions like osteoarthritis and obesity by increasing anti-inflammatory macrophages and preventing premature cellular senescence, while providing a non-invasive method to enhance omega-3 content in subjects.

Implementation Method 1

The introduction of the fat-1 gene, encoding an omega-3 desaturase, is delivered via viral vectors or engineered probiotic bacteria to convert omega-6 fatty acids to omega-3 fatty acids

Methodology Applied
Scientific EffectDesaturation:

Data Source

PatentUS20230059179A1Compositions and methods for regulating fatty acids
Publication Date: 2023.02.23 SHRINERS HOSPITALS FOR CRIPPLED CHILDREN
  • US20230059179A1 patent drawing
  • US20230059179A1 patent drawing
  • US20230059179A1 patent drawing

AI summary

Among the various aspects of the present disclosure relates to methods and compositions useful in convert inflammatory dietary fatty acids (omega 6) to anti-inflammatory fatty acids (omega 3). Specifically, the present disclosure provides methods and compositions for increasing n-3 desaturase expression or activity in a subject. The disclosure provides various compositions for providing increased n-3 desaturase expression or activity including a variety of viral vector and engineered microorganisms The disclosure provides, in part, methods for reducing local and/or systemic inflammation, improving wound healing, preventing premature cellular enescence, treating or preventing a disease, disorder, or condition related to inflammation or obesity and treating or preventing arthritis.